TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05269901 — Predictive Biomarker (PRD): CA3 mRNA
Genes: CA3
Study NCT05789355 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05289700 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05651880 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT05651880 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05824013 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT06062498 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06062498 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06559982 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05643976 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04831307 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05574335 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05574335 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06522750 — Predictive Biomarker (PRD): FASN mRNA
Genes: FASN; FAS
Study NCT06452251 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT06655545 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT06655545 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06655545 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06598930 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study NCT05670262 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT05315557 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT06448663 — Predictive Biomarker (PRD): Cyclin-dependent kinase-like 5
Genes: CDKL5; STK9
Study NCT05619068 — Predictive Biomarker (PRD): MMD mRNA
Genes: MMD; PAQR11
Study NCT05469178 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT05362786 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06742879 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06742879 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT05598320 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT04529538 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02271139 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06465810 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06272266 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06367088 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06125535 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT05755893 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05577143 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study NCT06084962 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT05827991 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT05827991 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06349980 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT06542458 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05651191 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04440501 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT05795751 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05795751 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05437601 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05357235 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04542382 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study NCT04932447 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06176534 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06176534 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06176534 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06478199 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT06478199 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT05306457 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study NCT05353530 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT05975905 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05975905 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04742686 — Safety Biomarker (SAF): BDNF
Study NCT06661915 — Safety Biomarker (SAF): CDA
Genes: CDD
Study NCT06672237 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT04461509 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05138848 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06696391 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05617872 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05617872 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT04739475 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT06381141 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MHC class I polypeptide-related sequence A
Genes: MICA; PERB11.1
Study NCT06381141 — Predictive Biomarker (PRD): MICB mRNA
Genes: MICB; PERB11.2
Study NCT06782243 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04535414 — Predictive Biomarker (PRD): Epithelial cadherin
Genes: CDH1; CDHE; UVO
Study NCT05929846 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT05511857 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05743530 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06485531 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05816785 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study NCT06519552 — Predictive Biomarker (PRD): IDUA mRNA
Genes: IDUA
Study NCT05360758 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05249374 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04577638 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06641310 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06450041 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06485700 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06560346 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study NCT06314191 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06314191 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06314191 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05616182 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study NCT04889716 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04777994 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04777994 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04777994 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05392985 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT05392985 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05096871 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05096871 — Safety Biomarker (SAF): BDNF
Study NCT05218122 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05313009 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03171545 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04932863 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06560528 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06562387 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT06536257 — Predictive Biomarker (PRD): PIP mRNA
Genes: PIP; GCDFP15; GPIP4
Study NCT05790824 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05377827 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT06594926 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT06616532 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06669338 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05672030 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT04741217 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05675033 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05675033 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05675033 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06472167 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05324306 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06211244 — Predictive Biomarker (PRD): Small-inducible cytokine A11
Genes: CCL11; SCYA11
Study NCT06351488 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study NCT06351488 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT05878964 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05878964 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05878964 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT05796154 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06167694 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04704323 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT04704323 — Predictive Biomarker (PRD): CCR7 mRNA
Genes: CCR7; CMKBR7; EBI1; EVI1
Study NCT04727398 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04727398 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00421694 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05339724 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05746806 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06237049 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06087289 — Predictive Biomarker (PRD): CX3CR1 mRNA
Genes: CX3CR1; CMKBRL1; GPR13
Study NCT05322967 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05292365 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT05029115 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05534139 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT04770597 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06562283 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT05350917 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05350917 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06080451 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05293535 — Predictive Biomarker (PRD): LRP6 mRNA
Genes: LRP6
Study NCT06562478 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05397938 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05193461 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05193461 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT05193461 — Safety Biomarker (SAF): BDNF
Study NCT04869592 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05673447 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06140420 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT05654571 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05861830 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05861830 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05861830 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05861830 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT06078215 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT06078215 — Predictive Biomarker (PRD): TJP1 mRNA
Genes: TJP1; ZO1
Study NCT05945290 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05945290 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06330896 — Predictive Biomarker (PRD): SH3PXD2A mRNA
Genes: SH3PXD2A; FISH; KIAA0418; SH3MD1; TKS5
Study NCT04841096 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT01723930 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05329311 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05329311 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05594095 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05594095 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05594095 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05594095 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06514807 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT06145282 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06635629 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT06635629 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05479448 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT06175663 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05039463 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05279742 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT06366815 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05879055 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05879055 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT05262530 — Predictive Biomarker (PRD): CLDN6 mRNA
Genes: CLDN6; UNQ757/PRO1488
Study NCT04872075 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00000728 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05384769 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05911308 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06503250 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT06561841 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT06525389 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06562309 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04966299 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT04699630 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04629144 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05470348 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06432751 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05457920 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01039363 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT01039363 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT05234788 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06042738 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06042738 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT05989555 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04817306 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06443671 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06094023 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06742125 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT05402579 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05554107 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06742060 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT06683768 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06696742 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06696235 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05353647 — Predictive Biomarker (PRD): BCL11A mRNA
Genes: BCL11A; CTIP1; EVI9; KIAA1809; ZNF856
Study NCT05642923 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05679024 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06532552 — Predictive Biomarker (PRD): Induced myeloid leukemia cell differentiation protein Mcl-1
Genes: MCL1; BCL2L3
Study NCT05563337 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05619692 — Predictive Biomarker (PRD): SAGE1 mRNA
Genes: SAGE1; SAGE
Study NCT05886634 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study NCT04994847 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06338826 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04489719 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06371807 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06371807 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06128629 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT04946864 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04784338 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04460937 — Predictive Biomarker (PRD): WEE1 mRNA
Genes: WEE1
Study NCT05910164 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05236348 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05893966 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04863014 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04863014 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study NCT04863014 — Predictive Biomarker (PRD): ANGPTL3 mRNA
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study NCT05003232 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05135104 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05135104 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06028204 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT05187208 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT06560593 — Predictive Biomarker (PRD): CFB mRNA
Genes: CFB; BF; BFD
Study NCT06469645 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05269069 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06511349 — Predictive Biomarker (PRD): PHC1 mRNA
Genes: PHC1; EDR1; PH1
Study NCT05984303 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05663892 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT06596018 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06366386 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06592144 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT06670053 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT06203119 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06626893 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT06714565 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06736990 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06743412 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06743139 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06741644 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04247243 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study NCT04914832 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04821999 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06561659 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05957549 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study NCT06402799 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT04864496 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05216185 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05441475 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study NCT06046820 — Predictive Biomarker (PRD): ENPP1 mRNA
Genes: ENPP1; M6S1; NPPS; PC1; PDNP1
Study NCT06218394 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT04708431 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT06644300 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04858126 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05107219 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT03905083 — Safety Biomarker (SAF): miR-133
Study NCT06523634 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT05817357 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06422351 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06218524 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study NCT06218524 — Safety Biomarker (SAF): DRD2
Study NCT06015035 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06244368 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04862767 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05651243 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05244213 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05834751 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF